HHS Shields Three Ebola Vaccine Makers From Legal Liability
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline, NewLink Genetics and Johnson & Johnson gain protection for their candidate Ebola vaccines; NewLink teams up with Merck, and GSK prepares for Phase II/III studies in West Africa.